Stockreport

TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics [Yahoo! Finance]

Kintara Therapeutics, Inc.  (KTRA) 
PDF Lead program entering single Phase 3 accelerated approval registration trial in first half of 2025 for treatment of 1 st line Merkel Cell carcinoma under Special Protoc [Read more]